The behavioral effects of hallucinogens in rats following 5,7-dihydroxytryptamine administration into the medial forebrain bundle.
Randall L. Commissaris, David J. Mokler, William H. Lyness, K E Moore, Richard H. Rech
Pharmacology, Biochemistry, and Behavior June 1981 DOI: 10.1016/0091-3057(81)90384-1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Controlled experimental animal study Peer reviewed |
|---|---|
| Population | Male rats |
| Interventions | 5 7-dihydroxytryptamine (5 7-DHT) lysergic acid diethylamide (LSD) 2 5-dimethoxy-4-methylamphetamine (DOM) mescaline |
| Dose | 6 micrograms/2 microliter of 5,7-DHT injected bilaterally into the medial forebrain bundle |
| Key findings | Lesioning serotonin neurons in the medial forebrain bundle with 5,7-DHT enhanced LSD's disruption of fixed ratio-40 bar-pressing, diminished DOM's effect, and did not change mescaline's effect. The authors suggest that serotonin neurons are involved in hallucinogen behavioral effects but that LSD, DOM, and mescaline may act at different sites or through different mechanisms. |
Abstract
The hypothesis that 5-hydroxytryptamine (5-HT) neurons and/or receptors are involved in the mechanism of action of hallucinogens is supported by the fact that intraventricular administration of the neurotoxin 5,7-dihydroxytryptamine (5,7-DHT) selectively destroys central 5-HT neurons in the brain and potentiates the behavioral effects of lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and mescaline. The locus in the brain where this potentiation might occur is not known. In the present experiment, the medial forebrain bundle (MFB) was studied because it is the primary tract containing fibers from the cell bodies in the raphe nuclei to forebrain structures receiving 5-HT input. Male rats received 5,7-DHT (6 micrograms/2 microliter) or vehicle injections bilaterally into the MFB; this procedure caused a significant reduction of 5-HT in the cortex, hippocampus and hypothalamus of lesioned rats, but not in the striatum. Regional dopamine and norepinephrine concentrations were not affected by this treatment. The behavioral effects of the hallucinogens were tested in a situation in which the animals pressed a bar under a fixed ratio-40 (FR-40) schedule of food reinforcement. The disruptive effects of LSD on responding were enhanced in the 5,7-DHT-treated animals, while the effects of DOM were diminished; there was no change in the response to mescaline. These data suggest that, while 5-HT neurons are involved in the behavioral effects of hallucinogens, the precise sites and/or mechanisms of action of LSD, DOM and mescaline may differ.
Citations in the library
Cited by 4
- Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride Pharmacology, Biochemistry, and Behavior August 1, 1984
- The effects of intracranial administration of hallucinogens on operant behavior in the rat. II. 2,5-Dimethoxy-4-methylamphetamine (DOM). Pharmacology, Biochemistry, and Behavior November 1987
- Naloxone alters the effects of LSD, DOM and quipazine on operant behavior of rats. Pharmacology, Biochemistry, and Behavior September 1984
- Neurotransmitter basis of the behavioral effects of hallucinogens. Neuroscience & Biobehavioral Reviews 1982
Cites 4
- Behavioral sensitivity to LSD: Dependency upon the pattern of central 5HT depletion Pharmacology, Biochemistry, and Behavior May 1, 1977
- Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats. Pharmacology, Biochemistry, and Behavior May 1981
- The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats. Pharmacology, Biochemistry, and Behavior November 1980
- Enhancement of the behavioral effects of 2,5-dimethoxy-4-methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine. Pharmacology, Biochemistry, and Behavior October 1980